# Effectiveness of the Association Artesunate and Mefloquine in the Treatment of Malaria by Plasmodium Falciparum

> **NCT01144702** · PHASE2,PHASE3 · COMPLETED · sponsor: **Oswaldo Cruz Foundation** · enrollment: 163 (actual)

## Conditions studied

- Falciparum Malaria

## Interventions

- **DRUG:** artesunate & mefloquine combination

## Key facts

- **NCT ID:** NCT01144702
- **Lead sponsor:** Oswaldo Cruz Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2013-04
- **Final completion:** 2014-07
- **Target enrollment:** 163 (ACTUAL)
- **Last updated:** 2015-05-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01144702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01144702, "Effectiveness of the Association Artesunate and Mefloquine in the Treatment of Malaria by Plasmodium Falciparum". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01144702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*